
Assertum 500mg/500mg Injection
Marketer
Cachet Pharmaceuticals Pvt Ltd
Salt Composition
Cefoperazone (500mg) + Sulbactam (500mg)
Overview Assertum 500mg/500mg Injection
Combiflox 500 mg/500 mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under a physician's guidance; adhere strictly to the prescribed schedule, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects require immediate medical attention. Seek immediate help for allergic reactions (e.g., skin rashes, pruritus, edema, dyspnea). Inform your doctor of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, driving is discouraged if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may order tests to monitor the drug's impact.
Primary Ingredients of Assertum 500mg/500mg Injection
There is no text provided to rephrase.
Uses of Assertum 500mg/500mg Injection
Managing Bacterial Infections
Major Benefits of Assertum 500mg/500mg Injection:
This medication will be administered by your physician or their qualified staff; please do not attempt self-medication.
Common Side effects of Assertum 500mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Assertum 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Assertum 500mg/500mg Injection works:
Assertum 500 mg/500 mg Injection combines Cefoperazone, a broad-spectrum antibiotic, with Sulbactam, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial survival. The addition of Sulbactam counteracts bacterial resistance mechanisms, optimizing Cefoperazone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol alongside Assertum 500 mg/500 mg Injection can lead to adverse effects including facial flushing, tachycardia, queasiness, excessive thirst, thoracic pain, and hypotension (a Disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable medication Assertum 500 mg/500 mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Assertum 500 mg/500 mg presents minimal breastfeeding risk. Research in humans indicates negligible transfer to breast milk, posing no apparent danger to infants.
DrivingCONSULT YOUR DOCTOR
The effect of Assertum 500 mg/500 mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Assertum 500 mg/500 mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Assertum 500 mg/500 mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Assertum 500mg/500mg Injection :
Should you forget a scheduled dose of Assertum 500 mg/500 mg Injection, seek advice from your physician.
Facts to Know About Assertum 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
